SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Abattis Bioceuticals Corp. (ATTBF)

ATTBF RSS Feed
Add ATTBF Price Alert      Hide Sticky   Hide Intro
Moderator: Goodbuddy4863, guay, captainscotty, ebota12, GreenBrickRoad, Campeese
Search This Board: 
Last Post: 4/24/2017 4:41:17 PM - Followers: 326 - Board type: Free - Posts Today: 14




Welcome to Abattis Bioceuticals Corp.
 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets.

Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.





Within our other divisions Northern Vine, North American Bioextracts and Biocube we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.

Northern Vine LaboratoriesTM (Northern Vine Labs
TM) seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada - Executive Overview

For more information, visit the Company's website at: www.abattis.com.





Our investors are forward thinkers in the emerging bioceutical and medical marijuana markets. We are a specialty, vertically-integrated biotechnology company that aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. From patented and proprietary formulations, extraction and processing methods, Abattis consistently seeks opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products. Abattis is uniquely positioned to fully exploit the growing trend toward marijuana legalization in the United States and medicinal use in Canada as licensed and international jurisdictions.





 

“Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion.
Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion”



We develop and license natural health products with unique botanical blends, CBD and proprietary ingredients. These infused food and beverage brands are designed for wellness nutraceuticals, medical foods & botanical drugs market with future plans to expand into the pharmaceutical and cosmetic markets.


As an investor, you are our partner and we take this relationship seriously. Please contact us if you have any questions or if you would like to invest in Abattis.
 

Goldman Small Cap Research report, 'This Stock Set to Double Thanks to New License'
Abattis Bioceuticals Corp. - Stock Up Big on Recent News, Greater Gains on Horizon (October 20, 2016).

Goldman Small Cap Research report 
'The Next Industry-Changing Specialty Health Stock'
Abattis Bioceuticals Corp. - Major Revenue Ahead for Innovative, Diversified Bioceuticals Pioneer (June 13, 2016).



Northern Vine Labs is getting ready for our launch.
 

Visit our website and join our community for updates and educational information.
#knowyourbud #abattis #northernvinelabs 





 

Northern Vine Labs™, a subsidiary of Abattis, seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada. The ability to legally work with Cannabis remains rare and highly specialized. Northern Vine Labs™ Controlled Substance License enables proprietary methods and services to be offered to currentlicensed producers within Canada’s existing Federal regulatory structure. It also offers Northern Vine Labs™ customers, including Abattis, the ability to formulate and develop new products containing cannabinoid ingredients in advance of the end to prohibition. The Cannabis Trade Alliance of Canada, which represents producers, said the new regime should provide for mandatory testing: 

“Mandatory laboratory testing of all cannabis products (potency and contaminants) – a critical step in the seed-to-sale process when considering public health, and should be the main objective in the legalized framework.”

Report of the Task Force on Cannabis Legalization and Regulation


 






Vergence Visionary Bioceuticals, a subsidiary of Abattis, is a team of nutraceutical marketing and brand specialists focused on innovative health products to penetrate the fast growing market for natural, safe and effective solutions to two of society’s unresolved and ubiquitous health issues: Pain caused by inflammation and mental ailments common to our modern lifestyle. Vergence is the exclusive exporter of 99.6%, organic and pure CBD Isolate out of Hong Kong and directly to the rest of the world. Together with a vast distribution network and custom product and branded formulations via Northern Vine Labs, Vergence aims to promote healthy living through natural remedies. Vergence is in possession of over 100 Natural Product Numbers (NPN's) as granted by Health Canada and plans to develop and distribute these products into global markets for end use.




Abattis Bioceuticals Corporation
Address: 104 - 9295 198th Street | Langley, BC V1M 3J9 | Canada
Phone: 778-883-7869 (Corporate Communications: Brook Bellian)
Email: news@abattis.com
Website: http://www.abattis.com


Abattis Bioceuticals
Phone: (604) 336.0881

Northern Vine
Phone: 
(604) 336.0881 | (604) 371.3371 | (604) 888.1129

CHINA | Dr. Shuang Xie  Ph. D.
Suzhou Raybot Material Tech Ltd
T: 17785884380 | C: 17783175968
Phone: 86 5125240581 | 8613901388668
Address:  No. 10-1 Yang Yuan Road,
Xinzhuang Zhen,Changshu | China



OUTSTANDING COMMON SHARE DATA
There are an unlimited number of common shares without par value authorized for issue. At September 30, 2016, there were 111,760,004 issued and fully paid common shares and 1,750,000 common shares in treasury.

Issued & Outstanding (03/19/2017)The Company has 144,321,560 common shares issued and outstanding (source
 

System for Electronic Document Analysis and Retrieval (SEDAR) - www.sedar.com






 

04/10/2017 | Abattis Bioceuticals Announces New CEO
04/06/2017 | Abattis Gets Added to the Marijuana Index by MJIC
04/04/2017 | Near-term Legalization Puts Testing into Focus
03/27/2017 | Next Month - Legislation to Legalize Marijuana in CA
03/20/2017 | Dr. David Galvez - New Science Advisor of Northern Vine
03/13/2017 | Abattis Team Positions for Next Stage of Growth
03/07/2017 | LP Highlights Continued Need for Testing
02/25/2017 | Abattis Prepares to Launch Northern Vine Labs
02/24/2017 | Abattis Annual Report - September 30, 2016
02/14/2017 | Abattis Audit Update
02/08/2017 | Key Shortcomings in Canada's Cannabis Industry
02/03/2017 | Abattis Audit Update
12/16/2016 | Abattis Provides Corporate Update
12/09/2016 | $ 5 Million Facility with Aluminia Partners
11/15/2016 | Dr. Shuang Xie - Director and CTA
11/09/2016 | Licensing Deal and Brand Acouisition
11/07/2016 | Renewal of Health Canada Licence
11/02/2016 | Appointment of New Independent Director
10/24/2016 | Agreement to Acquire 100% of Experion
10/17/2016 | Experion Prepares for Construction
10/05/2016 | MOU with Global Damon Pharma of South Korea
10/03/2016 | Northern Vine Receives Controlled Substance Licence









If you want to add or to change something on this site - send a message to guay.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ATTBF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ATTBF News: Withdrawal of Registration Statement (rw) 12/09/2016 06:05:17 AM
PostSubject
#29239  Sticky Note ABATTIS BIOCEUTICALS: Joins an Index and Runs with captainscotty 04/16/17 08:15:16 AM
#28981  Sticky Note Report of the Task Force on Cannabis Legalization guay 04/11/17 08:13:53 AM
#28851  Sticky Note READ!!!: Abattis Bioceuticals Announces New CEO Vancouver, British Columbia--(N StockWhale 04/10/17 10:12:58 AM
#28505  Sticky Note ATTBF Now Listed on the Marijuana Index-Biotechnology sector: Goodbuddy4863 04/02/17 07:18:06 PM
#27284  Sticky Note Goldman Research thinks ATTBF could blow through $0.30+ GreenBrickRoad 10/21/16 11:19:22 AM
#26399  Sticky Note Corporate Update ebota12 11/05/15 07:31:44 PM
#12064  Sticky Note BOARD WARNING - Please Read: IH Admin [Shelly] 06/09/14 01:18:32 PM
#29412   Abattis Bioceuticals (ATTBF) put up good today … fine guay 04/24/17 04:41:17 PM
#29411   True, but doesn't matter.... Att_for_life 04/24/17 01:46:13 PM
#29410   Lol weak, inexperienced investors will sell and I'm SeeingGreen420 04/24/17 11:42:13 AM
#29409   FACT: In this post, I forgot to ebota12 04/24/17 11:04:25 AM
#29408   DJIA up 200 points, Google up $13.+, Apple Skittles9 04/24/17 09:58:37 AM
#29407   Sell one of your... Att_for_life 04/24/17 07:46:01 AM
#29406   #ATTBF: #10 Break Out Board...:-}Go Guay captainscotty 04/24/17 07:06:12 AM
#29405   15 … maybee 15 - 12 I doubt guay 04/24/17 06:51:00 AM
#29404   Oh yeah baby!! Att_for_life 04/24/17 05:32:42 AM
#29403   Yeah I smell that too... Att_for_life 04/24/17 05:18:52 AM
#29402   Thank You - I will add this … guay 04/24/17 04:13:51 AM
#29400   isn't it? … I meant to memorize or guay 04/24/17 03:53:07 AM
#29399   An interesting conundrum... Att_for_life 04/24/17 01:12:48 AM
#29398   https://m.canadianinsider.com/company?menu_tickersearch=ATT%20%7C%20Abattis%20Bi ebota12 04/23/17 10:14:08 PM
#29397   Commemorate...that's hilarious! StormanNorman 04/23/17 09:06:18 PM
#29396   Agree … guay 04/23/17 08:26:14 PM
#29395   :-D … that's what I call a oxymoron guay 04/23/17 07:49:18 PM
#29394   'ebota12' please tell us your source … guay 04/23/17 07:30:22 PM
#29393   don't be so trusting of PRs... Att_for_life 04/23/17 06:04:00 PM
#29392   Nope! Not a beginner, started day trading during 420toInfinity 04/23/17 05:31:00 PM
#29391   Are u a beginner? Att_for_life 04/23/17 05:11:55 PM
#29390   Probably true worth: Att_for_life 04/23/17 05:06:21 PM
#29389   Ok.... Att_for_life 04/23/17 04:52:29 PM
#29388   FACT: It's not Goldman Sachs. It's ebota12 04/23/17 04:11:31 PM
#29387   Lots of dissenting opinions on here. Can we 420toInfinity 04/23/17 03:47:25 PM
#29386   GBR, we all know what we're waiting for StormanNorman 04/23/17 12:55:45 PM
#29385   True, it's not hot off the press, but GreenBrickRoad 04/23/17 12:49:35 PM
#29384   Guay, ALL old news! StormanNorman 04/23/17 12:28:52 PM
#29383   The Complex World of Cannabis Lab Testing: Dangerous guay 04/23/17 11:49:34 AM
#29382   Northern Vine Labs - Canada’s Plans for Near-term guay 04/23/17 11:43:27 AM
#29381   Valens GroWorks Acquires Licensed Cannabis Testing Lab guay 04/23/17 11:42:37 AM
#29380   LAB TESTING: MARIJUANA’S NEXT BILLION-DOLLAR MARKET guay 04/23/17 11:42:03 AM
#29379   Marijuana Testing labs are the mystery of the guay 04/23/17 11:41:17 AM
#29378   3 1/2 years later and I know ATTBF's SeeingGreen420 04/23/17 11:40:51 AM
#29377   I called the number... Att_for_life 04/23/17 12:45:01 AM
#29376   IMHO, you're totally wrong. ebota12 04/22/17 09:51:53 AM
#29375   #ATTBF:Could make it to $2.00 ...:-}Go SeeingGreen captainscotty 04/22/17 08:57:31 AM
#29374   Selling now is a huge mistake with Northern SeeingGreen420 04/22/17 08:05:18 AM
#29373   Yup, still got my .12 order ready:) Att_for_life 04/21/17 10:58:04 PM
#29372   RE: post 29349 Mr Hand 04/21/17 08:01:18 PM
#29371   @post 29349 Mr Hand 04/21/17 07:58:25 PM
#29370   I picked up shades at $.181. Raise your cdaniel394 04/21/17 05:46:10 PM
#29369   Hmmm I don't think so, I've had this SeeingGreen420 04/21/17 05:04:26 PM
#29368   SeeingGreen, I do believe every day that passes StormanNorman 04/21/17 04:05:05 PM
#29367   If there are some impatient sellers out there SeeingGreen420 04/21/17 03:34:07 PM
#29366   Dear day 54.... Att_for_life 04/21/17 01:06:40 PM
#29365   Just think about the big picture... Stock was dangerx 04/21/17 11:10:43 AM
#29364   great post, thanks! ebota12 04/21/17 11:02:20 AM
#29363   Once again the $.20 support is holding strong, SeeingGreen420 04/21/17 10:59:54 AM
#29362   Bonus, as described March 16. They sucked ebota12 04/21/17 10:58:52 AM
PostSubject